Key result
Female sex linked to ~16% lower mortality in type 2 MI vs men.
Why the study?
Type 2 myocardial infarction is heterogeneous and whether clinical characteristics, investigations, and outcomes differ between women and men is unknown.
Does sex influence clinical characteristics, cardiac investigations, and all-cause mortality or MACE outcomes in patients with type 2 myocardial infarction?
Cohort (n=63,749)
Yes
Does sex influence clinical characteristics, cardiac investigations, and all-cause mortality or MACE outcomes in patients with type 2 myocardial infarction?
Unlike type 1 MI, type 2 MI affects men and women equally without sex differences in diagnostic investigation rates, though women have less obstructive CAD or LV dysfunction and better survival than men.
May support sex-specific prognosis in type 2 MI; leaves open mechanisms and need for prospective validation.
OBJECTIVES: Type 2 myocardial infarction (MI) is a heterogenous condition and whether there are differences between women and men is unknown. We evaluated sex differences in clinical characteristics, investigations and outcomes in patients with type 2 MI. METHODS: In the Swedish Web based system for Enhancement and Development of Evidence based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) registry, we compared patients admitted to coronary care units with a diagnosis of type 1 or type 2 MI. Sex-stratified Cox regression models evaluated the association with all-cause death in men and women separately. RESULTS: We included 57 264 (median age 73 years, 65% men) and 6485 (median age 78 years, 50% men) patients with type 1 and type 2 MI, respectively. No differences were observed in the proportion of men and women with type 2 MI who underwent echocardiography and coronary angiography, but women were less likely than men to have left ventricular (LV) impairment and obstructive coronary artery disease (CAD). Compared with type 1 MI, patients with type 2 MI had higher risk of death regardless of sex (men: adjusted HR 1.55 (95% CI 1.44 to 1.67); women: adjusted HR 1.34 (95% CI 1.24 to 1.45)). In those with type 2 MI, the risk of death was lower for women than men (adjusted HR 0.85 (95% CI 0.76 to 0.92) (men, reference)). CONCLUSIONS: Type 2 MI occurred in men and women equally and we found no evidence of sex bias in the selection of patients for cardiac investigations. Patients with type 2 MI had worse outcomes, but women were less likely to have obstructive CAD or severe LV impairment and were more likely to survive than men.
No takes yet. Share an insight, caveat, or question.
Kimenai et al. (2021) conducted a cohort in Type 1 or Type 2 Myocardial Infarction (n=63,749). Female sex in type 2 myocardial infarction vs. Male sex in type 2 myocardial infarction (reference) was evaluated on All-cause death in patients with type 2 myocardial infarction (HR 0.84, 95% CI 0.76 to 0.92, p=≤0.001). Women with type 2 MI had a significantly lower risk of all-cause mortality than men (45% vs 50%, adjusted HR 0.84, 95% CI 0.76-0.92, p≤0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: